Package leaflet: Information for the User Clarityn 1 mg/ml syrup Loratadine

Similar documents
Package leaflet: Information for the User Clarityn 10 mg tablets Loratadine

Package leaflet: Information for the patient. Histaclar 10 mg Film-coated Tablets loratadine

PACKAGE LEAFLET: INFORMATION FOR THE USER. ZADITEN 1 mg/5 ml Oral Solution. Ketotifen (as Ketotifen hydrogen fumarate)

Package leaflet: Information for the patient. Loratadine 10 mg Tablets (loratadine)

Package leaflet: Information for the patient. Flynise 5 mg Orodispersible Tablets desloratadine

Package leaflet: Information for the user. Relestat, 0.5 mg/ml, eye drops, solution Epinastine hydrochloride

Package leaflet: Information for the patient

PACKAGE LEAFLET: INFORMATION FOR THE USER ZIRPINE 10mg TABLETS Cetirizine dihydrochloride

Package leaflet: Information for the patient

Package leaflet: Information for the user. Lorastad 10 mg Tablets loratadine

PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET. Active substances: Each 5 ml syrup (1 spoon) contains 2.5 mg desloratadine.

Package leaflet: Information for the user. Ondansetron 4mg/5ml Syrup (ondansetron as ondansetron hydrochloride dihydrate)

Zofran syrup contains a medicine called ondansetron. This belongs to a group of medicines called anti-emetics.

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT

Benylin Children's Coughs & Colds 5mg/0.625mg per 5ml Syrup dextromethorphan, triprolidine

PACKAGE LEAFLET: INFORMATION FOR THE USER. DUKORAL suspension and effervescent granules for oral suspension Cholera vaccine (inactivated, oral)

PACKAGE LEAFLET: INFORMATION FOR THE USER Paracodin 0.20% w/w Syrup (dihydrocodeine hydrogen tartrate)

Package leaflet: Information for the user. PRED MILD STERILE OPHTHALMIC SUSPENSION 0.12% w/v Eye Drops, Suspension Prednisolone Acetate

Package leaflet: Information for the patient

1 What Engerix B is and what it is used for

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT. ILAXTEN 20 MG TABLETS bilastine

Package leaflet: Information for the patient. Vertigon 8 mg Tablets Vertigon 16 mg Tablets (betahistine dihydrochloride)

Havrix Monodose Vaccine Hepatitis A Vaccine (Inactivated, adsorbed) ELISA Units/1 ml Suspension for Injection in a pre-filled syringe

1. What Octostim Nasal Spray is and what it is used for

Package leaflet: Information for the user. Elaprase 2 mg/ml concentrate for solution for infusion idursulfase

1. What Betahistine dihydrochloride tablets is and what it is used for

Atrosan Devil s Claw film-coated tablets

Package leaflet: Information for the patient. / / 30 mg/5 ml syrup. Ambroxol hydrochloride

Package leaflet: Information for the user. Carmellose sodium

Package Leaflet: Information for the user. LUMIGAN 0.3 mg/ml, eye drops, solution, in single-dose container Bimatoprost

PACKAGE LEAFLET: INFORMATION FOR THE USER. NEFOXEF 120 MG FILM-COATED TABLETS NEFOXEF 180 MG FILM-COATED TABLETS Fexofenadine hydrochloride

Package leaflet: Information for the user. Colecalciferol 3000 IU/ml Oral Solution (colecalciferol)

Package leaflet: Information for the patient. IKERVIS 1 mg/ml, eye drops, emulsion ciclosporin

PACKAGE LEAFLET: INFORMATION FOR THE USER RENNIE DUAL ACTION TABLETS. Calcium carbonate, Magnesium carbonate, Alginic acid Chewable tablets

Suspension for injection in pre-filled syringe Diphtheria, tetanus and pertussis (acellular component) vaccine (adsorbed, reduced antigen content)

Package Leaflet: Information for the patient. Movicol Ready to Take oral solution in sachet

PACKAGE LEAFLET: INFORMATION FOR THE USER. Bydureon 2 mg powder and solvent for prolonged-release suspension for injection in pre-filled pen exenatide

Sibelium 5 mg Tablets flunarizine

Package leaflet: Information for the user. Catacrom 2 % w/v Eye Drops, Solution. Sodium cromoglicate

PACKAGE LEAFLET: INFORMATION FOR THE USER ACULAR 0.5% w/v EYE DROPS, SOLUTION (Ketorolac trometamol)

Package leaflet: Information for the user Zirtek Allergy Relief for Children 1 mg/ml Oral Solution Cetirizine dihydrochloride

Zofran syrup contains a medicine called ondansetron. This belongs to a group of medicines called anti-emetics.

Benylin Phlegm Cough Menthol 100mg/5ml Oral Solution Guaifenesin

Package leaflet: Information for the user

Package leaflet: Information for the user. Lycimor 300 mg Hard Capsules Lymecycline (equivalent to 300mg of tetracycline base)

Package Leaflet: Information for the user. NEVANAC 3 mg/ml eye drops, suspension nepafenac

Package leaflet: Information for the patient

Package leaflet: Information for the user. NEVANAC 1 mg/ml eye drops, suspension Nepafenac

Package leaflet: Information for the user. Ebateva 20 mg Orodispersible Tablets. Ebastine

2. What you need to know before you take DDAVP/Desmopressin Tablets

POLLENTYME S and Tabs Pharma Dynamics (Pty) Ltd Version: July 2017 (G1639) Word copy of G1639 PATIENT INFORMATION LEAFLET FOR POLLENTYME S AND TABS

PATIENT INFORMATION LEAFLET POLLENTYME S AND TABS

PACKAGE LEAFLET: INFORMATION FOR THE USER. Ambrobene 3 mg/ml Oral Solution Ambroxol hydrochloride

Package leaflet: Information for the patient. xylometazoline hydrochloride

Package Leaflet: Information for the user Baclofen 5mg/5ml Oral Solution

PACKAGE LEAFLET: INFORMATION FOR THE USER. Venaforce Varicose Veins gastro-resistant tablets Horse Chestnut seed dry extract

THORENS I.U. /2.5 ml oral solution. Cholecalciferol (vitamin D 3 )

Package leaflet: Information for the patient. Hexvix 85 mg, powder and solvent for intravesical solution Hexaminolevulinate

Package leaflet: Information for the patient. SIRTURO 100 mg tablets Bedaquiline

Package leaflet: Information for the user. Cefixime ABR 100 mg/5 ml powder for oral suspension Cefixime

Package leaflet: Information for the user. Floxapen 250 mg & 500 mg Capsules. Flucloxacillin

PACKAGE LEAFLET: INFORMATION FOR THE USER. Tantum Verde orange-honey taste 3 mg lozenges Benzydamine Hydrochloride

Imodium 1 mg/5 ml oral solution

Package leaflet: Information for the patient LOCABIOTAL Pressurised 125 micrograms Nasal/Oromucosal spray solution Fusafungine

PACKAGE LEAFLET: INFORMATION FOR THE USER. Folic Acid 2.5mg/5ml Oral Solution Folic Acid 2.5mg/5ml

Package leaflet: Information for the patient. Forxiga 5 mg film-coated tablets Forxiga 10 mg film-coated tablets dapagliflozin

PACKAGE LEAFLET: INFORMATION FOR THE USER

Package leaflet: Information for the user Oftaquix 5 mg/ml eye drops, solution. Levofloxacin

PACKAGE LEAFLET: INFORMATION FOR THE USER. GRAZAX 75,000 SQ-T oral lyophilisate

TYPHIM Vi, Solution for injection

Package leaflet: Information for the patient. Verkazia 1 mg/ml eye drops emulsion ciclosporin

PACKAGE LEAFLET: INFORMATION FOR THE USER. Xylonase 0.1% w/v Nasal Spray, Solution Xylometazoline hydrochloride

Proctosedyl Ointment Hydrocortisone/Cinchocaine hydrochloride/framycetin sulphate/aesculin

Package Leaflet: Information for the user. TARGAXAN 550 mg film-coated tablets rifaximin

Package leaflet: Information for the user

Maxilief Effervescent Tablets

Package leaflet: Information for the user. Zirtek 1 mg/ml oral solution. Cetirizine dihydrochloride

Package leaflet: Information for the patient. Paracetamol 10 mg/ml solution for infusion. Paracetamol

PRED FORTE 1% w/v Eye Drops, Suspension Prednisolone acetate

Zofran tablets contain a medicine called ondansetron. This belongs to a group of medicines called anti-emetics.

Package leaflet: Information for the user. Zomig 2.5 mg tablets zolmitriptan

Package leaflet: Information for the patient. Olumiant 2 mg film-coated tablets Olumiant 4 mg film-coated tablets Baricitinib

Echinaforce Hot Drink

Package Leaflet: Information for the user. Methocarbamol 750mg Film-Coated Tablets

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT. DRYNOL 20 MG TABLETS bilastine

ANBESOL TM Anaesthetic Antiseptic Oromucosal solution Lidocaine hydrochloride 0.90%w/w, Chlorocresol 0.10%w/w, Cetylpyridinium Chloride 0.

Package Leaflet: Information for the user Kemadrin 5 mg Tablets Procyclidine hydrochloride

Package leaflet: Information for the patient

Package leaflet: Information for the user. Raxone 150 mg film-coated tablets idebenone

PACKAGE LEAFLET: INFORMATION FOR THE USER. Otrivin Menthol (without preservative) 1 mg/ml nasal spray, solution Xylometazoline hydrochloride

Package leaflet: Information for the user. Burinex 5 mg Tablets bumetanide

Package Leaflet: Information for the user

PACKAGE LEAFLET: INFORMATION FOR THE USER. Pneumococcal Polysaccharide Vaccine

Transcription:

Package leaflet: Information for the User Clarityn 1 mg/ml syrup Loratadine Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. Always take this medicine exactly as described in this leaflet or as your doctor, pharmacist, or nurse has told you. - Keep this leaflet. You may need to read it again. - Ask your pharmacist if you need more information or advice. - If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet.see section 4. - You must talk to a doctor if you do not feel better or if you feel worse. See section 4. What is in this leaflet: 1. What Clarityn is and what it is used for 2. What you need to know before you take Clarityn 3. How to take Clarityn 4. Possible side effects 5 How to store Clarityn 6. Contents of the pack and other information 1. What Clarityn is and what it is used for The full name of your medicine is Clarityn syrup. What Clarityn is Clarityn syrup contains the active substance loratadine which belongs to a class of medicines called antihistamines. How Clarityn works Clarityn helps to reduce your allergy symptoms by stopping the effects of a substance called histamine, which is produced in the body when you are allergic to something. When Clarityn should be taken Clarityn relieves symptoms associated with allergic rhinitis (for example, hay fever), such as sneezing, runny or itchy nose, and burning or itchy eyes in adults and children over the age of 2 years. Clarityn may also be used to help relieve symptoms of urticaria (itching, redness and number and size of hives). The effect of Clarityn will last a whole day and should help you to continue your normal daily activities and sleep. You must talk to a doctor if you do not feel better or if you feel worse. 2. What you need to know before you take Clarityn Do not take Clarityn if 1

you are allergic (hypersensitive) to loratadine or any of the other ingredients of this medicine (listed in section 6). Warnings and precautions Talk to your doctor, pharmacist or nurse before taking Clarityn if: you have liver disease you are scheduled to have any skin tests for allergies. Do not take Clarityn for two days before having these tests. This is because it may affect test results. If any of the above apply to you (or you are not sure), talk to your doctor, pharmacist or nurse before taking Clarityn. Children Do not give Clarityn to children younger than 2 years old. Other medicines and Clarityn The side effects of Clarityn may increase when used together with medicines that alter the performance of some enzymes responsible for drug-metabolism in the liver. However, in clinical studies, no increase in side effects of loratadine was seen with products that altered the performance of these enzymes. Tell your doctor, pharmacist or nurse if you are taking, have recently taken or might take any other medicines. This includes medicines obtained without a prescription. Clarityn with alcohol Clarityn has not been shown to add to the effects of an alcoholic drink. Pregnancy and breast-feeding If you are pregnant, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. As a precautionary measure, it is preferable to avoid the use of Clarityn during pregnancy. Do not take Clarityn if you are breast-feeding. Loratadine is excreted in breast milk. Driving and using machines In clinical trials that assessed driving ability, no impairment was observed in patients receiving loratadine. At the recommended dose, Clarityn is not expected to cause you to be drowsy or less alert. However, very rarely some people experience drowsiness, which may affect their ability to drive or use machines. Clarityn contains: Maltitol liquid: This medicine contains 3 g maltitol liquid in each spoonful (5 ml) which is equivalent to 600.69 mg/ml. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine. Sorbitol: This medicine contains 700 mg sorbitol in each spoonful (5 ml) which is equivalent to 140 mg/ml. Sorbitol is a source of fructose. If your doctor has told you that you (or your child) have an intolerance to some sugars or if you have been diagnosed with hereditary fructose intolerance (HFI), a rare genetic disorder in which a person cannot break down fructose, talk to your doctor before you (or your child) take or receive this medicine. Propylene glycol: This medicine contains 250 mg propylene glycol in each spoonful (5 ml) which is equivalent to 50 mg/ml. Sodium: This medicine contains less than 1 mmol sodium (23 mg) per spoonful (5 ml), that is to say essentially sodium-free. 2

Sodium benzoate: This medicine contains 2.5 mg sodium benzoate in each spoonful (5 ml) which is equivalent to 0.5 mg/ml. 3. How to take Clarityn Always take this medicine exactly as described in this leaflet or as your doctor, pharmacist or nurse has told you. Check with your doctor, pharmacist or nurse if you are not sure. How much to take: Adults and children over 12 years of age: Take two spoonfuls (10 ml) once daily. Children aged 2 to 12 years are dosed by weight: Body weight more than 30 kg: Take two spoonfuls (10 ml) once daily. Body weight 30 kg or less: Give one spoonful (5 ml) once daily. Clarityn is not recommended for children younger than 2 years old. Adults and children with severe liver problems: Adults and children who weigh more than 30 kg: Take two spoonfuls (10 ml) once every other day. Children who weigh 30 kg or less: Give one spoonful (5 ml) once every other day. However, you should talk to your doctor, pharmacist or nurse before taking this medicine. Taking this medicine Water or other liquid is not needed to swallow the syrup The syrup may be taken with or without food. If you take more Clarityn than you should If you take more Clarityn than you should, talk to your doctor or pharmacist straight away. No serious problems are expected however, you may get a headache, have a rapid heartbeat or feel sleepy. If you forget to take Clarityn If you forget to take your dose, take it as soon as you remember, then continue to take it as usual. Do not take a double dose to make up for a forgotten dose. If you have any further questions on the use of this medicine, ask your doctor,pharmacist or nurse. 4. Possible side effects Like all medicines, this medicine can cause side effects, although not everybody gets them. The most commonly reported side effects in adults and children over 12 years of age are: drowsiness headache 3

increased appetite difficulty sleeping. The most commonly reported side effects in children aged 2 through 12 years are: headache nervousness tiredness. The following very rare side effects (may affect up to 1 in 10,000 people) have also been seen during the marketing of loratadine: severe allergic reaction (including swelling) dizziness convulsion fast or irregular heartbeat nausea (feeling sick) dry mouth upset stomach liver problems hair loss rash tiredness. The frequency of the following side effect is not known (frequency cannot be estimated from the available data): weight increased. Reporting of side effects If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via HPRA Pharmacovigilance, Earlsfort Terrace, IRL Dublin 2; Tel: +353 1 6764971; Fax: +353 1 6762517. Website: www.hpra.ie; Email: medsafety@hpra.ie. By reporting side effects you can help provide more information on the safety of this medicine. 5. How to store Clarityn Keep this medicine out of the sight and reach of children. Do not freeze. Keep the bottle in the outer carton in order to protect from light.do not use this medicine after the expiry date which is stated on the bottle after EXPIRY. The expiry date refers to the last day of that month. Clarityn syrup is to be used within 1 month after opening. Do not use this medicine if you notice any change in the appearance of the syrup. Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment. 6. Contents of the pack and other information What Clarityn contains The active substance is loratadine. Each 10 ml of the syrup contains 10 mg loratadine. 4

The other ingredients are disodium edetate (E386), sodium dihydrogen phosphate dihydrate (E339), maltitol liquid (E965), propylene glycol (E1520), glycerol (E422), phosphoric acid (E338), sodium benzoate (E211), sorbitol liquid (E420), sucralose (E955), artificial mixed berry flavour and purified water. What Clarityn looks like and contents of the pack Syrup. Clear colourless to light yellow syrup. Clarityn syrup is available in opaque white plastic bottles of 60, 120 or 150 ml with a tamper-evident, child-proof plastic cap. A 5 ml plastic spoon is included. Not all bottle sizes may be marketed. Marketing Authorisation Holder and Manufacturer Marketing Authorisation Holder: Bayer Limited, The Atrium, Blackthorn Road, Dublin 18. Manufacturer: Berlimed S.A. Poligono Industrial Santa Rosa Calle Francisco Alonso No.7 28806 Alcalá de Henares (Madrid) Spain This medicinal product is authorised in the Member States of the EEA under the following names: Belgium, Luxemburg, Netherlands, Portugal: Claritine Denmark, Iceland, Ireland, Italy, Sweden: Clarityn France, Greece, Spain: Clarityne UK: Clarityn (Allergy) This leaflet was last approved in October 2017. 5